NCT05670106 2026-02-13
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC
Novartis
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT06134232 2025-08-27
ProvONE
Dendreon
Phase 2 Recruiting
NCT05658003 2025-08-22
A Study Evaluating [177Lu]Lu-PSMA-617 vs. a Change of Androgen Receptor-directed Therapy in Taxane Treatment Naive Chinese Male Patients With Progressive Metastatic Castrate Resistant Prostate Cancer
Novartis
Phase 2 Active not recruiting
NCT04015622 2025-08-20
PROTRACT
British Columbia Cancer Agency
Phase 2 Active not recruiting
NCT03712930 2021-11-17
Treatment of Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
BeiGene
Phase 2 Terminated